Hydrogen Isotope Fractionation Factors for Benzylamine and Benzylammonium Ion. Comparison of Fractionation Factors for Neutral and Positively-Charged Nitrogen-Hydrogen Bonds
Abstract:Deuterium-protium fractionation factors were determined for benzylamine and benzylammonium ion by the traditional 1H N M R method and for the benzylammonium ion by a newly devised 13C N M R method. The results, 4phCH2NL2 = 0.958 f 0.070 and 4phCH2NL,+ = 1.081 f 0.019, when combined with the solvent isotope effect on the ionization of benzylammonium ion, also determined here, K H / K D = 3.36 f 0.13, give @ P~C H~N L , += 0.80 f 0.13 as the medium effect for transfer of this ion from H20 to D20. These results s… Show more
“…[α-13 C]Methyltrimethylammonium iodide was prepared previously. 4 The identities of these substances were confirmed by their 1 H NMR spectra. All other materials were best available commercial grades.…”
Section: Methodsmentioning
confidence: 87%
“…than that for the neutral N᎐L bonds of benzylamine, 2, φ = 0.96. 4 Examination of vibrational frequencies of NL 4 + and NL 3 as surrogates for PhCH 2 NL 3 + and PhCH 2 NL 2 showed that the expected bond weakening accompanying positive charge introduction was indeed reflected in lowered stretching vibra- † The special symbol 'l ' is generally used for the fractionation factor of the hydronium ion. ‡ The symbol 'L' denotes either protium or deuterium, i.e.…”
“…[α-13 C]Methyltrimethylammonium iodide was prepared previously. 4 The identities of these substances were confirmed by their 1 H NMR spectra. All other materials were best available commercial grades.…”
Section: Methodsmentioning
confidence: 87%
“…than that for the neutral N᎐L bonds of benzylamine, 2, φ = 0.96. 4 Examination of vibrational frequencies of NL 4 + and NL 3 as surrogates for PhCH 2 NL 3 + and PhCH 2 NL 2 showed that the expected bond weakening accompanying positive charge introduction was indeed reflected in lowered stretching vibra- † The special symbol 'l ' is generally used for the fractionation factor of the hydronium ion. ‡ The symbol 'L' denotes either protium or deuterium, i.e.…”
“…One factor that may increase or decrease φ, but is unrelated to bond stretching frequency differences in the solvent and solute sites, is a change in bending frequencies accompanying H-bond formation in the solute (52). For instance, fractionation studies on N,N-substituted benzylammonium ions by Kresge and co-workers have shown that anomalously high φ values may result from compensatory increases in bond bending vibration frequencies upon H bond formation (53,54). Thus, a strong hydrogen bond that undergoes a decrease in stretching frequency as compared to solvent may have a larger than expected φ value because of a compensatory increase in a bending vibration frequencies.…”
Section: N Chemical Shift and Scalar Coupling Constant Implicationsmentioning
Uracil DNA glycosylase (UDG) cleaves the glycosidic bond of deoxyuridine in DNA using a hydrolytic mechanism, with an overall catalytic rate enhancement of 10(12)-fold over the solution reaction. The nature of the enzyme-substrate interactions that lead to this large rate enhancement are key to understanding enzymatic DNA repair. Using (1)H and heteronuclear NMR spectroscopy, we have characterized one such interaction in the ternary product complex of Escherichia coli UDG, the short (2.7 A) H bond between His187 N(epsilon)(2) and uracil O2. The H bond proton is highly deshielded at 15.6 ppm, indicating a short N-O distance and exhibits a solvent exchange rate that is 400- and 10(5)-fold slower than free imidazole at pH 7.5 and pH 10, respectively. Heteronuclear NMR experiments at neutral pH show that this H bond involves the neutral imidazole form of His187 and the N1-O2 imidate form of uracil. The excellent correspondence of the pK(a) for the disappearance of the H bond (pK(a) = 6.3 +/- 0.1) with the previously determined pK(a) = 6.4 for the N1 proton of enzyme-bound uracil indicates that the H bond requires negative charge on uracil O2 [Drohat, A. C., and Stivers, J. T. (2000) J. Am. Chem. Soc. 122, 1840-1841]. Although the above characteristics suggest a short strong H bond, the D/H fractionation factor of phi = 1.0 is more typical of a normal H bond. This unexpected observation may reflect a large donor-acceptor pK(a) mismatch or the net result of two opposing effects on vibrational frequencies: decreased N-H bond stretching frequencies (phi < 1) and increased bending frequencies (phi > 1) relative to the O-H bonds of water. The role of this H bond in catalysis by UDG and several approaches to quantify the H bond energy are discussed.
“…The first is the difference in basicity of these amines. Benzylamine has a p K a of 9.36 (43), whereas that of H‐ l ‐Phe‐OEt is 2 units lower (7.23,44). This difference in p K a makes the environment of the Boc‐ l ‐Ser(Bzl)‐OH/benzylamine‐mediated condensation more basic than that of the Boc‐ l ‐Ser(Bzl)‐OH/H‐ l ‐Phe‐OEt (Table 2, entry 3), with the consequence that racemization increased to 1.8%.…”
This study towards the development of sulfurane-based coupling agents shows that bis-[alpha,alpha-bis(trifluoromethyl)-benzyloxy]diphenylsulfur (BTBDS) can facilitate rapid amide bond formation between Nalpha-urethane-protected l-amino acids and l-phenylalanine ethyl ester in the absence of an external base. The corresponding dipeptide esters were obtained in excellent yields and with no detectable racemization, as judged by analysis of the formed dipeptides by chiral-phase HPLC. In addition, BTBDS-mediated condensation of benzoyl-l-phenylalanine with l-phenylalanine ethyl ester was also investigated. The results indicate that sulfuranes can be useful for application in racemization-sensitive systems, such as segment condensation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.